Reviewing your investment strategy: Where does diet fit in your personal portfolio

American Journal of Clinical Nutrition

Volumn 81, Issue 2, 2005, Pages 339-340

  Denke, Margo A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAR GUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN;

CHOLESTEROL INTAKE; CLINICAL TRIAL; DIET THERAPY; DISEASE CONTROL; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; INVESTMENT; LIFESTYLE; RISK FACTOR; VEGETARIAN DIET; BLOOD; DIET; NOTE; TREATMENT OUTCOME;

CYAMOPSIS TETRAGONOLOBA; PLANTAGO OVATA;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; DIET; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; TREATMENT OUTCOME;

EID: 14544293625     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn.81.2.339     Document Type: Editorial

References (11)

1. Jenkins DJA, Kendall CWC, Marchie A, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 2005;81:380-7.
2. Napoli C, Sica V. Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile. Curr Pharm Design 2004;10:425-32.
3. Denke MA. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am J Clin Nutr 1995;62(suppl):471S-7S.
4. Glatz JF, Turner PR, Katan MB, Stalenhoef AF, Lewis B. Hypo- and hyperresponse of serum cholesterol level and low density lipoprotein production and degradation to dietary cholesterol in man. Ann N Y Acad Sci 1993;676:163-79.
5. Hirsch GA, Vaid N, Blumenthal RS. Perspectives: the significance of measuring non-HDL cholesterol. Prev Cardiol 2002;5:156-9.
6. deLorgeril M, Salen P, Caillat-Vallet E, Hanauer MT, Barthelemy JC, Mamelle N. Control of bias in dietary trial to prevent coronary recurrences: The Lyon Diet Heart Study. Eur J Clin Nutr 1997;51:116-22.
7. Lichenstein AH, Jalbert SM, Adlercreutz H, et al. Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 2002;22:1852-8.
8. Knopp RH, Superko HR, Davidson M, et al. Long term blood cholesterol lowering effects of a dietary fiber supplement. Am J Prev Med 1999;17: 18-23.
9. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol lowering effects of dietary fiber: a meta analysis. Am J Clin Nutr 1999;69:30-42.
10. Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases. Ann Med 2004;36:126-34.
11. Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD. The effects of nuts on coronary heart disease risk. Nutr Rev 2001;59:103-11.